Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2013.00120
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Targeting Nuclear Factor Kappa B for the Treatment of Prostate Cancer

2005English

Resistance to Metronomic Chemotherapy and Ways to Overcome It

Cancer Letters
Cancer ResearchOncology
2017English

Nuclear Factor Kappa B in Liver Disease

Gut
Gastroenterology
1999English

Targeting Efflux Pumps to Overcome Antifungal Drug Resistance

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2016English

Retraction: Nuclear Factor Kappa-B Signaling Is Integral to Ocular Neovascularization in Ischemia-Independent Microenvironment

PLoS ONE
Multidisciplinary
2019English

The Metabolic Response to Inflammation in Astrocytes Is Regulated by Nuclear Factor-Kappa B Signaling

GLIA
Molecular NeuroscienceNeurologyCellular
2020English

Targeting of erbB3 Receptor to Overcome Resistance in Cancer Treatment

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2014English

Targeting Tumor Associated Macrophages to Overcome Conventional Treatment Resistance in Glioblastoma

Frontiers in Pharmacology
Pharmacology
2020English

Asbestos Induces Nuclear Factor Kappa B (NF-kappa B) DNA-binding Activity and NF-kappa B-Dependent Gene Expression in Tracheal Epithelial Cells.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy